Early kinetics of intravenous propranolol. 1982

T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
December 1990, Cardiovascular drugs and therapy,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
February 1984, Clinical pharmacology and therapeutics,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
June 1985, Journal of pharmacokinetics and biopharmaceutics,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
December 1986, Klinische Wochenschrift,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
October 1968, Archives des maladies du coeur et des vaisseaux,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
October 1979, British journal of clinical pharmacology,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
January 1977, Journal of medicine,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
March 1989, Journal of clinical pharmacology,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
January 1979, Clinical pharmacology and therapeutics,
T C Fagan, and T Walle, and U K Walle, and E C Conradi, and G Harmon, and T E Gaffney
November 1980, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!